Duffield, Amy S. http://orcid.org/0000-0003-2018-1964
Mullighan, Charles G. http://orcid.org/0000-0002-1871-1850
Borowitz, Michael J.
Funding for this research was provided by:
National Cancer Institute, National Institutes of Health (P30 CA008748, R35 CA197695, P30 CA021765, U10 CA180886)
Article History
Received: 15 August 2022
Revised: 21 October 2022
Accepted: 27 October 2022
First Online: 24 November 2022
Declarations
: The contents of Tables InternalRef removed, InternalRef removed, InternalRef removed, and InternalRef removed are similar to those published in “Arber DA et al. [CitationRef removed]” because the current review expands on the International Consensus Classification first described in the June 2022 manuscript; however, the contents of the current manuscript have not been copyrighted.
: Authors A.S.D. and M.J.B. declare no competing interests. Author C.G.M. has received speaker (Illumina and Amgen) and consultant (Faze, Beam) honoraria, and receives research funding from AbbVie and Pfizer.